{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:45:45Z","timestamp":1792035945579,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.ejphar.2005.02.019","type":"journal-article","created":{"date-parts":[[2005,3,18]],"date-time":"2005-03-18T09:42:40Z","timestamp":1111138960000},"page":"191-198","source":"Crossref","is-referenced-by-count":105,"title":["Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model"],"prefix":"10.1016","volume":"511","author":[{"given":"Surya P.","family":"Ayalasomayajula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday B.","family":"Kompella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2005.02.019_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2337\/diacare.21.1.143","article-title":"Diabetic retinopathy","volume":"21","author":"Aiello","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2005.02.019_bib2","first-page":"1181","article-title":"Diffusion of high molecular weight compounds through sclera","volume":"41","author":"Ambati","year":"2000","journal-title":"Invest. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.ejphar.2005.02.019_bib3","series-title":"Microparticles but not nanoparticles are retained in the subconjunctival space at 2-months post-administration","author":"Amrite","year":"2004"},{"key":"10.1016\/j.ejphar.2005.02.019_bib4","first-page":"408","article-title":"Sustained release of the antimetabolite 5-fluorouridine-5\u2032-monophosphate by multivesicular liposomes","volume":"19","author":"Assil","year":"1988","journal-title":"Ophthalmic Surg."},{"key":"10.1016\/j.ejphar.2005.02.019_bib5","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1023\/A:1014438800893","article-title":"A biodegradable injectable implant sustains systemic and ocular delivery of an aldose reductase inhibitor and ameliorates biochemical changes in a galactose-fed rat model for diabetic complications","volume":"19","author":"Aukunuru","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejphar.2005.02.019_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0014-2999(02)02043-5","article-title":"Induction of vascular endothelial growth factor by 4-hydroxynonenal and its prevention by glutathione precursors in retinal pigment epithelial cells","volume":"449","author":"Ayalasomayajula","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.02.019_bib7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0014-2999(02)02793-0","article-title":"Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model","volume":"458","author":"Ayalasomayajula","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.02.019_bib9","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1023\/B:PHAM.0000045231.51924.e8","article-title":"Retinal delivery of celecoxib is several-fold higher following subconjunctival administration compared to systemic administration","volume":"21","author":"Ayalasomayajula","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejphar.2005.02.019_bib10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ejphar.2004.07.046","article-title":"Inhibition of cyclooxygenase-2, but not cyclooxygenase-1, reduces prostaglandin E2 secretion from diabetic rat retinas","volume":"498","author":"Ayalasomayajula","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.02.019_bib11","first-page":"1153","article-title":"Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes","volume":"41","author":"Barouch","year":"2000","journal-title":"Invest. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.ejphar.2005.02.019_bib12","first-page":"591","article-title":"Increased cytochrome oxidase activity in the diabetic rat retinal pigment epithelium","volume":"30","author":"Caldwell","year":"1989","journal-title":"Invest. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.ejphar.2005.02.019_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/09629350020025764","article-title":"Effect of cyclosporin-A on the blood\u2013retinal barrier permeability in streptozotocin-induced diabetes","volume":"9","author":"Carmo","year":"2000","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ejphar.2005.02.019_bib14","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1167\/iovs.01-1156","article-title":"Controlled delivery of the anti-VEGF aptamer EYE001 with poly(lactic-co-glycolic)acid microspheres","volume":"44","author":"Carrasquillo","year":"2003","journal-title":"Invest. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.ejphar.2005.02.019_bib15","first-page":"62","article-title":"Retinal delivery of sodium fluorescein, budesonide, and celecoxib following subconjunctival injection","volume":"3","author":"Cheruvu","year":"2003","journal-title":"Drug Deliv. Technol."},{"key":"10.1016\/j.ejphar.2005.02.019_bib16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1081\/PDT-100100542","article-title":"Kinetics of a model nucleoside (guanosine) release from biodegradable poly(dl-lactide-co-glycolide) microspheres: a delivery system for long-term intraocular delivery","volume":"5","author":"Chowdhury","year":"2000","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejphar.2005.02.019_bib17","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3109\/10715769809065818","article-title":"Lipid peroxidation and biogenic aldehydes: from the identification of 4-hydroxynonenal to further achievements in biopathology","volume":"28","author":"Comporti","year":"1998","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.ejphar.2005.02.019_bib18","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1023\/A:1016249812466","article-title":"Evaluation of poly(isobutylcyanoacrylate) nanoparticles for mucoadhesive ocular drug delivery: I. Effect of formulation variables on physicochemical characteristics of nanoparticles","volume":"12","author":"Das","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejphar.2005.02.019_bib19","first-page":"299","article-title":"Oxidative stress in diabetic retina","volume":"62","author":"Doly","year":"1992","journal-title":"EXS"},{"key":"10.1016\/j.ejphar.2005.02.019_bib20","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1096\/fasebj.12.12.1063","article-title":"Cyclooxygenase in biology and disease","volume":"12","author":"Dubois","year":"1998","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2005.02.019_bib21","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra021678","article-title":"Diabetic retinopathy","volume":"350","author":"Frank","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2005.02.019_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.neo.7900127","article-title":"Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis","volume":"3","author":"Gallo","year":"2001","journal-title":"Neoplasia"},{"key":"10.1016\/j.ejphar.2005.02.019_bib23","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1165\/ajrcmb.17.6.2888","article-title":"Prostaglandins induce vascular endothelial growth factor in a human monocytic cell line and rat lungs via cAMP","volume":"17","author":"Hoper","year":"1997","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ejphar.2005.02.019_bib24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0002-9440(10)63952-1","article-title":"Leukocyte-mediated endothelial cell injury and death in the diabetic retina","volume":"158","author":"Joussen","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2005.02.019_bib25","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1096\/fj.01-0707fje","article-title":"Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression","volume":"16","author":"Joussen","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2005.02.019_bib26","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/cne.10400","article-title":"Cellular localization of cyclooxygenase-1 and cyclooxygenase-2 in the normal mouse, rat, and human retina","volume":"452","author":"Ju","year":"2002","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ejphar.2005.02.019_bib27","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/S0161-6420(89)32699-6","article-title":"The Wisconsin epidemiologic study of diabetic retinopathy: XI. The incidence of macular edema","volume":"96","author":"Klein","year":"1989","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejphar.2005.02.019_bib28","first-page":"28","article-title":"Poly (lactic acid) nanoparticles for sustained release of budesonide","volume":"1","author":"Kompella","year":"2001","journal-title":"Drug Deliv. Technol."},{"key":"10.1016\/j.ejphar.2005.02.019_bib29","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1167\/iovs.02-0791","article-title":"Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression","volume":"44","author":"Kompella","year":"2003","journal-title":"Invest. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.ejphar.2005.02.019_bib30","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1172\/JCI118962","article-title":"Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo","volume":"98","author":"Kuroki","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2005.02.019_bib31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1096\/fasebj.13.1.23","article-title":"Contributions of polyol pathway to oxidative stress in diabetic cataract","volume":"13","author":"Lee","year":"1999","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2005.02.019_bib32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-4165(99)00056-2","article-title":"Generation of active oxygen species from advanced glycation end-products (AGEs) during ultraviolet light A (UVA) irradiation and a possible mechanism for cell damaging","volume":"1428","author":"Masaki","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2005.02.019_bib33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0014-2999(00)00286-7","article-title":"Early changes in lipid peroxidation and antioxidative defense in diabetic rat retina: effect of DL-alpha-lipoic acid","volume":"398","author":"Obrosova","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.02.019_bib34","first-page":"1546","article-title":"Regulation of retinal vascular endothelial growth factor and receptors in rabbits exposed to hyperoxia","volume":"43","author":"Ozaki","year":"2002","journal-title":"Invest. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.ejphar.2005.02.019_bib35","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1089\/ars.1999.1.3-255","article-title":"4-Hydroxynonenal as a biological signal: molecular basis and pathophysiological implications","volume":"1","author":"Parola","year":"1999","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ejphar.2005.02.019_bib36","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/01.CIR.0000080735.93327.00","article-title":"Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy","volume":"108","author":"Sennlaub","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2005.02.019_bib37","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/oxfordjournals.ndt.a027888","article-title":"Oxidative stress as the triggering event for vascular remodelling","volume":"13","author":"Silacci","year":"1998","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejphar.2005.02.019_bib38","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1179\/135100003225002673","article-title":"The retina: oxidative stress and diabetes","volume":"8","author":"van Reyk","year":"2003","journal-title":"Redox Rep."},{"key":"10.1016\/j.ejphar.2005.02.019_bib39","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1365-2796.2002.00932.x","article-title":"Diabetes and advanced glycation endproducts","volume":"251","author":"Vlassara","year":"2002","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ejphar.2005.02.019_bib40","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/bj2450243","article-title":"Glucose autoxidation and protein modification. The potential role of \u2018autoxidative glycosylation\u2019 in diabetes","volume":"245","author":"Wolff","year":"1987","journal-title":"Biochem. J."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299905001706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299905001706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T11:21:40Z","timestamp":1549279300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299905001706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":39,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0014299905001706"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2005.02.019","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}